Velabs Therapeutics GmbH

Velabs is a leading pioneer in microfluidics-based technologies for functional screening of antibodies. Their high-throughput screening platform allows for testing millions of correctly paired fully natural IgGs from humans and mice for therapeutic effects, rather than just for binding. Rare functional hits are readily identified, which might be laborious using other technologies. Velabs’ antibody screens can thus significantly and competitively shorten pre-clinical development.